Cipla Patents – Insights & Stats

Cipla has a total of 3490 patents globally, out of which 1470 have been granted. Of these 3490 patents, more than 61% patents are active. India is where Cipla has filed the maximum number of patents, followed by United States Of America and Europe. Parallelly, India seems to be the main focused R&D center and is also the origin country of Cipla.

Cipla was founded in 1935 by Khwaja Abdul Hamied. Cipla manufactures and sells pharmaceutical and personal care products. The Company offers active pharmaceutical ingredients, and formulations in therapeutic areas, such as allergy, analgesic, anti-malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, steroids, iron chelators, nutritional products. As of May 2022, Cipla has a market cap of $10.35 Billion.

Do read about some of the most popular patents of Cipla which have been covered by us in this article and also you can find Cipla patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cipla patent portfolio.

How many patents does the CEO of Cipla have?

The CEO, Umang Vohra has 0 patents.

How many patents does Cipla have?

Cipla has a total of 3490 patents globally. These patents belong to 1090 unique patent families. Out of 3490 patents, 1328 patents are active.

How Many Patents did Cipla File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCipla Applications FiledCipla Patents Granted
201018580
2011176102
201296123
201317698
201412282
201510998
20168353
201710330
20189944
20196242
20203423
20212233
2022412

Which Cipla Drug Patents are Expiring in the Next 10 Years?

The patent no. US9688711B2 which is expiring in Nov, 2028, describing a potent antibacterial drug, derived from a complex hydrophobic molecule with a structure similar to proteins rather than simple DNA motifs, is effective for treating bacterial infections.

Given below is the list of few drugs patented by Cipla accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
ZemdriUS9688711B2Antibacterial Aminoglycoside AnalogsNov, 2028

How many Cipla patents are Alive/Dead?

Worldwide Patents

How Many Patents did Cipla File in Different Countries?

Countries in which Cipla Filed Patents

CountryPatents
India677
United States Of America314
Europe229
Australia204
Canada163
Japan160
South Africa158
Korea (South)151
New Zealand99
Germany91
China80
Russia76
Brazil70
United Kingdom66
Mexico59
Hong Kong (S.A.R.)40
Spain35
Austria32
Turkey31
Israel30
Argentina25
Indonesia22
Singapore21
Viet Nam21
Portugal20
Malaysia20
Morocco18
Poland18
Philippines17
Chile17
Denmark16
Peru14
United Arab Emirates13
Tunisia12
Panama11
Uruguay10
Taiwan10
Cyprus9
Dominican Republic9
Slovenia9
Norway8
Ecuador8
Iceland8
Costa Rica7
Hungary6
Latvia5
Ukraine5
Croatia4
Kazakhstan4
Czech Republic4
Colombia4
Switzerland4
Romania4
Greece3
Jordan3
Lithuania3
Laos3
Egypt3
El Salvador2
Honduras2
Italy2
Botswana2
Brunei2
Georgia2
Serbia1
Macao1
Bulgaria1
Rwanda1
Bolivia1
Luxembourg1
Estonia1
Azerbaijan1
Slovakia1
Paraguay1
San Marino1
Belarus1
Kenya1
Kyrgyzstan1
Bangladesh1

Where are Research Centers of Cipla Patents Located?

10 Best Cipla Patents

US20040213744A1 is the most popular patent in the Cipla portfolio. It has received 163 citations so far from companies like Medpharm Limited and Arcion Therapeutics.

Below is the list of 10 most cited patents of Cipla:

Publication NumberCitation Count
US20040213744A1163
US6962691B1129
WO2004019985A1113
WO2007007110A183
WO2008035109A179
WO2006024863A175
US7022698B267
WO2005108386A157
US6348458B155
WO2010067072A155

Which Companies are using Cipla Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Cipla patent portfolio are 3M, O-Ray Pharma and Afgin Pharma.

List of the top forward citing Companies –

CompanyNumber Of Patents
3M2
O-Ray Pharma2
Mexichem Fluor Sa De Cv2
Afgin Pharma2
Ratiopharm2
Althera Life Sciences2
Leo Pharma A/S2
Chiesi Farmaceutici Spa2
Neuroderm2
Daiichi Sankyo2

Count of 102 and 103 Type Rejections based on Cipla Patents

Top Cipla Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US6962691B17
US20040213744A17
US7638627B26
US8168620B26
US20070219171A15
US20070286814A15
US8269003B24
US8633234B24
US9968771B24
US8962601B23

What Percentage of Cipla US Patent Applications were Granted?

Cipla (Excluding its subsidiaries) has filed 274 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 152 have been granted leading to a grant rate of 61.04%.

Below are the key stats of Cipla patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Cipla?

Law FirmTotal ApplicationsSuccess Rate
Conley Rose13763.78%
Meunier Carlin & Curfman4273.53%
Macmillan Sobanski & Todd2213.64%
Cooley1172.73%
Polsinelli1050.00%
Bass Berry & Sims580.00%
Dykema Gossett540.00%
Venable5100.00%
Cantor Colburn40.00%
Haynes And Boone425.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Cipla key innovation segments?

What Technologies are Covered by Cipla?

The chart below distributes patents filed by Cipla in different countries on the basis of the technology protected in patents. It also represents the markets where Cipla thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cipla’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cipla?

Related Articles

Rapoo Patents – Insights & Stats (Updated 2024)

Rapoo has a total of 562 patents globally, out of which 507 have been granted. Of these 562 patents, more than 31% patents are active. China is where Rapoo has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, China seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.